does tesamorelin cause joint pain: Frequently asked questions

Egrifta SV may cause serious side effects, including:

Egrifta SV (tesamorelin) is an injectable prescription medicine used to reduce the excess stomach-area (abdominal) fat in HIV-infected adult patients with lipodystrophy. Egrifta SV is a growth hormone-releasing factor (GHRF). The long-term safety of Egrifta SV on the heart and blood vessels (cardiovascular) is not known. Egrifta SV is not for weight loss management. It is not known whether taking Egrifta SV helps improve how well you take (compliance with) antiretroviral medicines. It is not known if Egrifta SV is safe and effective in children.

Common side effects of Tesamorelin include:

Tesamorelin is a prescription medication used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.

If your medical doctor is using this medicine to treat your pain, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider, or pharmacist first.